Search results
Viking (VKTX) Announces Clinical Data for Metabolic Disorders
Zacks via Yahoo Finance· 1 year agoViking (VKTX) announces positive clinical data, evaluating VK2735 to treat metabolic disorders. It...
As Viking Therapeutics, Inc. (NASDAQ:VKTX) gains 8.7%, insiders who bought last year may be wishing...
Simply Wall St. via Yahoo Finance· 1 year agoViking Therapeutics, Inc. (NASDAQ:VKTX) insiders who bought shares over the past year were rewarded...
Biotech Stock Roundup: VKTX, BMEA, ITCI Soar on Study Data, INCY Faces Setback
Zacks via Yahoo Finance· 1 year agoThe biotech sector has been in focus in the past week with key pipeline and regulatory updates....
Individual investors account for 50% of Viking Therapeutics, Inc.'s (NASDAQ:VKTX) ownership, while...
Simply Wall St. via Yahoo Finance· 1 year agoEvery investor in Viking Therapeutics, Inc. (NASDAQ:VKTX) should be aware of the most powerful...
Viking Therapeutics, Inc. (NASDAQ:VKTX) Q4 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 3 months agoViking Therapeutics, Inc. (NASDAQ:VKTX) Q4 2024 Earnings Call Transcript February 7, 2024 Viking...
We're Not Very Worried About Viking Therapeutics' (NASDAQ:VKTX) Cash Burn Rate
Simply Wall St. via Yahoo Finance· 1 year agoJust because a business does not make any money, does not mean that the stock will go down. Indeed,...
Why Viking Therapeutics Stock Wobbled Today
Motley Fool· 1 year agoShares of clinical-stage biotech Viking Therapeutics (NASDAQ: VKTX) fell by as much as 4.8% on exceptionally low volume during the first hour of trading...
Ligand (LGND) Up 4% on Raised '23 EPS, Beats on Q2 Earnings
Zacks via Yahoo Finance· 9 months agoLigand Pharmaceuticals (LGND) reports second-quarter results as earnings beat the estimates, but...
Madrigal (MDGL) Stock Up as FDA Approves First Drug for NASH
Zacks via Yahoo Finance· 2 months agoMadrigal Pharmaceuticals MDGL announced that the FDA has granted accelerated approval to its drug,...
Akero Therapeutics (AKRO) Up on Positive Data from NASH Study
Zacks via Yahoo Finance· 2 years agoAkero Therapeutics (AKRO) reports positive top-line data from a mid-stage study evaluating its lead...
